TSX Venture Exchange:RX

<!-- Name:DistributionId Value:8830315 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8830314 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8785370 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8783438 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8783439 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an exclusive Distribution Agreement with a…

MISSISSAUGA, Ontario, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in…

MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2022 Bloom Burton & Co. Healthcare Investor Conference. The…

MISSISSAUGA, Ontario, 19 oct. 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent »,« la Société », Bourse de croissance TSX : RX) a le plaisir d’annoncer le lancement de FeraMAXMD Pd Poudre 15 par sa filiale, BioSyent Pharma Inc, au…